A high intake of conjugated linoleic acid does not affect liver and kidney function tests in healthy human subjects

Food Chem Toxicol. 2010 Feb;48(2):587-90. doi: 10.1016/j.fct.2009.11.036. Epub 2009 Nov 22.

Abstract

Conjugated linoleic acid (CLA) is consumed widely as a supplement. It causes hepatomegaly in animals, but toxicological data in humans are limited. We therefore studied the effect of a high daily intake of CLA on liver and kidney function in healthy subjects. Twenty subjects received 14.6 g cis-9,trans-11 CLA and 4.7 g trans-10,cis-12 CLA isomers a day for 3 weeks. Liver and kidney function was measured at 0, 3, 7, 10, 16, and 21 days. Mean values of all tests remained within normal limits. Lactate dehydrogenase (mean+/-SD) increased from 290.9+/-43.6 to 322.5+/-60.7 U/L (p=0.04) on day 21. One subject exceeded the upper limit of normal of 450 U/L on day 21, to 472 U/L and another showed an isolated elevation to 555 U/L on day 7. Gamma-glutamyltranspeptidase increased from 12.1+/-5.9 to 13.5+/-6.2U/L (p=0.002). No one exceeded the upper limit of 50 U/L for men and 40 U/L for women. A daily intake of 19.3 g CLA for 3 weeks does not produce clinically relevant effects on markers of liver and kidney function in healthy volunteers.

Trial registration: ClinicalTrials.gov NCT00449462.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Clinical Chemistry Tests
  • Dietary Supplements
  • Female
  • Humans
  • Kidney / drug effects*
  • Kidney / physiology
  • Kidney Function Tests
  • L-Lactate Dehydrogenase / blood
  • Linoleic Acids, Conjugated / administration & dosage*
  • Liver / drug effects*
  • Liver / physiology
  • Liver Function Tests
  • Male
  • Middle Aged
  • Reference Values
  • Young Adult
  • gamma-Glutamyltransferase / blood

Substances

  • Linoleic Acids, Conjugated
  • L-Lactate Dehydrogenase
  • gamma-Glutamyltransferase

Associated data

  • ClinicalTrials.gov/NCT00449462